JP2003137727A - Skin care preparation - Google Patents
Skin care preparationInfo
- Publication number
- JP2003137727A JP2003137727A JP2001336752A JP2001336752A JP2003137727A JP 2003137727 A JP2003137727 A JP 2003137727A JP 2001336752 A JP2001336752 A JP 2001336752A JP 2001336752 A JP2001336752 A JP 2001336752A JP 2003137727 A JP2003137727 A JP 2003137727A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- sausage
- antioxidant
- components
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 26
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000001648 tannin Substances 0.000 claims abstract description 8
- 229920001864 tannin Polymers 0.000 claims abstract description 8
- 235000018553 tannin Nutrition 0.000 claims abstract description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 6
- 239000011732 tocopherol Substances 0.000 claims abstract description 6
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000021466 carotenoid Nutrition 0.000 claims abstract description 5
- 150000001747 carotenoids Chemical class 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003799 tocopherol Natural products 0.000 claims abstract description 5
- 229960001295 tocopherol Drugs 0.000 claims abstract description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 4
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 4
- 102000002933 Thioredoxin Human genes 0.000 claims abstract description 4
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 claims abstract description 4
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 claims abstract description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930003935 flavonoid Natural products 0.000 claims abstract description 4
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 4
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 4
- 235000004515 gallic acid Nutrition 0.000 claims abstract description 4
- 229940074391 gallic acid Drugs 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 229940094937 thioredoxin Drugs 0.000 claims abstract description 4
- 108060008226 thioredoxin Proteins 0.000 claims abstract description 4
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 4
- 241000201323 Kigelia Species 0.000 claims abstract 3
- 235000002329 Kigelia pinnata Nutrition 0.000 claims description 22
- 239000000419 plant extract Substances 0.000 claims description 21
- 244000062767 Kigelia africana Species 0.000 claims 4
- -1 lipid peroxides Chemical class 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 18
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 239000000203 mixture Substances 0.000 abstract description 14
- 239000000284 extract Substances 0.000 abstract description 9
- 230000003405 preventing effect Effects 0.000 abstract description 9
- 238000009472 formulation Methods 0.000 abstract description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 5
- 239000001301 oxygen Substances 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 238000007788 roughening Methods 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000012071 phase Substances 0.000 description 21
- 244000014603 Kigelia pinnata Species 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 235000013580 sausages Nutrition 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- 239000008213 purified water Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 239000006071 cream Substances 0.000 description 9
- 229930182470 glycoside Natural products 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 230000037303 wrinkles Effects 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 4
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 235000005513 chalcones Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- FEPAFOYQTIEEIS-UHFFFAOYSA-N 2',5'-Bis(3,4,5-trihydroxybenzoyl)-beta-D-Furanose-2-C-Hydroxymethylribose Natural products OC1C(COC(=O)C=2C=C(O)C(O)=C(O)C=2)(O)C(O)OC1COC(=O)C1=CC(O)=C(O)C(O)=C1 FEPAFOYQTIEEIS-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- FEPAFOYQTIEEIS-IZUGRSKYSA-N [(2r,3r,4r)-3,4,5-trihydroxy-4-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxolan-2-yl]methyl 3,4,5-trihydroxybenzoate Chemical compound C([C@H]1OC([C@@]([C@@H]1O)(O)COC(=O)C=1C=C(O)C(O)=C(O)C=1)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 FEPAFOYQTIEEIS-IZUGRSKYSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 229930003949 flavanone Natural products 0.000 description 3
- 235000011981 flavanones Nutrition 0.000 description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 244000305267 Quercus macrolepis Species 0.000 description 2
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- AYMYWHCQALZEGT-ORCRQEGFSA-N butein Chemical compound OC1=CC(O)=CC=C1C(=O)\C=C\C1=CC=C(O)C(O)=C1 AYMYWHCQALZEGT-ORCRQEGFSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- XHEFDIBZLJXQHF-UHFFFAOYSA-N fisetin Chemical compound C=1C(O)=CC=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 XHEFDIBZLJXQHF-UHFFFAOYSA-N 0.000 description 2
- 150000002208 flavanones Chemical class 0.000 description 2
- 229930003939 flavanonol Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
- 235000011957 flavonols Nutrition 0.000 description 2
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 2
- 229920002824 gallotannin Polymers 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C(O)=C1 FBSFWRHWHYMIOG-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 2
- KYLWJAUHHPTDDH-UHFFFAOYSA-N primetin Chemical compound OC1=CC=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 KYLWJAUHHPTDDH-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- PADQINQHPQKXNL-LSDHHAIUSA-N (+)-dihydrokaempferol Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C=C1 PADQINQHPQKXNL-LSDHHAIUSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- PPRMAMORBLMPSR-MDZDMXLPSA-N (e)-1-(2,5-dihydroxy-3,4,6-trimethoxyphenyl)-3-phenylprop-2-en-1-one Chemical compound OC1=C(OC)C(OC)=C(O)C(OC)=C1C(=O)\C=C\C1=CC=CC=C1 PPRMAMORBLMPSR-MDZDMXLPSA-N 0.000 description 1
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical compound O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 description 1
- HYSJQRYYQGEYMY-BQYQJAHWSA-N 2,5-dihydroxy-3-methoxy-6-[(e)-3-phenylprop-2-enoyl]cyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C(OC)=C(O)C(=O)C(C(=O)\C=C\C=2C=CC=CC=2)=C1O HYSJQRYYQGEYMY-BQYQJAHWSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 241001090347 Bignoniaceae Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 102100033007 Carbonic anhydrase 14 Human genes 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- FNUPUYFWZXZMIE-UHFFFAOYSA-N Fustin Natural products O1C2=CC(O)=CC=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 101000867862 Homo sapiens Carbonic anhydrase 14 Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- PPRMAMORBLMPSR-UHFFFAOYSA-N Pedicin Natural products OC1=C(OC)C(OC)=C(O)C(OC)=C1C(=O)C=CC1=CC=CC=C1 PPRMAMORBLMPSR-UHFFFAOYSA-N 0.000 description 1
- UJYIYFMMZPFRGH-UHFFFAOYSA-N Pedicinin Natural products COC1=C(O)C(=O)C(=C(O)C1=O)C=Cc2ccccc2 UJYIYFMMZPFRGH-UHFFFAOYSA-N 0.000 description 1
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004216 Rhodoxanthin Substances 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- UIDUJXXQMGYOIN-UHFFFAOYSA-N aromadendrin Natural products CC1(C)C2C1CCC(C)C1C2C(C)CC1 UIDUJXXQMGYOIN-UHFFFAOYSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- RAYJUFCFJUVJBB-UHFFFAOYSA-N dihydrokaempferol Natural products OC1Oc2c(O)cc(O)cc2C(=O)C1c3ccc(O)cc3 RAYJUFCFJUVJBB-UHFFFAOYSA-N 0.000 description 1
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011990 fisetin Nutrition 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FNUPUYFWZXZMIE-HUUCEWRRSA-N fustin Chemical compound C1([C@@H]2[C@@H](C(C3=CC=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-HUUCEWRRSA-N 0.000 description 1
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N iso-octadecanoic acid Natural products CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- SUYJZKRQHBQNCA-LSDHHAIUSA-N pinobanksin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=CC=C1 SUYJZKRQHBQNCA-LSDHHAIUSA-N 0.000 description 1
- URFCJEUYXNAHFI-ZDUSSCGKSA-N pinocembrin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-ZDUSSCGKSA-N 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000019246 rhodoxanthin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- DJOJDHGQRNZXQQ-AWEZNQCLSA-N sakuranetin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)OC)=CC=C(O)C=C1 DJOJDHGQRNZXQQ-AWEZNQCLSA-N 0.000 description 1
- RNAPFFYGJWALAQ-UHFFFAOYSA-N sakuranetin Natural products O1C2=CC(C)=CC(O)=C2C(=O)CC1C1=CC=C(O)C=C1 RNAPFFYGJWALAQ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- RGNXWPVNPFAADO-NSIKDUERSA-N sulfuretin Chemical compound O1C2=CC(O)=CC=C2C(=O)\C1=C\C1=CC=C(O)C(O)=C1 RGNXWPVNPFAADO-NSIKDUERSA-N 0.000 description 1
- RGNXWPVNPFAADO-UHFFFAOYSA-N sulfuretin Natural products O1C2=CC(O)=CC=C2C(=O)C1=CC1=CC=C(O)C(O)=C1 RGNXWPVNPFAADO-UHFFFAOYSA-N 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 230000037330 wrinkle prevention Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】この発明は、皮膚の肌荒れ及
び老化防止作用に優れ、皮膚中での活性酸素生成に起因
する過酸化脂質の生成や、肌の炎症,肌荒れを防止ある
いは改善する効果を有する皮膚外用剤に関する。詳細に
は、ソーセージノキ属植物抽出物と、抗酸化成分から選
択される1種又は2種以上を配合した、皮膚外用剤に関
する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention has an excellent effect of preventing rough skin and aging of the skin, and has the effect of preventing or improving lipid peroxide generation due to active oxygen generation in the skin, and skin inflammation and rough skin. The present invention relates to a skin external preparation. More specifically, the present invention relates to a skin external preparation containing a sausage tree plant extract and one or more selected from antioxidant components.
【0002】[0002]
【従来の技術】紫外線や内在性酸素に起因する酸化スト
レスの皮膚に及ぼす悪影響が明らかになるにつれ、抗酸
化作用を有する物質の皮膚外用剤への応用が検討されて
きた。これら抗酸化性物質としては、ビタミンE類、ビ
タミンC類といった抗酸化性ビタミン類が代表的なもの
として挙げられる。2. Description of the Related Art As the adverse effects of oxidative stress caused by ultraviolet rays and endogenous oxygen on the skin have been revealed, application of substances having an antioxidant effect to external preparations for skin has been investigated. Typical examples of these antioxidant substances include antioxidant vitamins such as vitamin Es and vitamin Cs.
【0003】しかしながら、上記の抗酸化性ビタミン類
は、光や酸化剤に対して不安定であったり、安定性を改
善した誘導体においても抗酸化活性が十分ではなく、皮
膚外用剤に配合して十分有効な効果を得るには、かなり
高濃度必要で、外用剤の剤型によっては溶解性の問題か
ら配合が困難であったり、製剤安定性に悪影響を及ぼし
たりすることがあった。However, the above-mentioned antioxidative vitamins are unstable to light and oxidants, and even the derivatives having improved stability do not have sufficient antioxidative activity, and therefore, they have been incorporated into a skin external preparation. In order to obtain a sufficiently effective effect, a considerably high concentration is required, and depending on the dosage form of the external preparation, formulation may be difficult due to solubility problems, or formulation stability may be adversely affected.
【0004】[0004]
【発明が解決しようとする課題】抗酸化効果が相乗的に
増強され、少量の配合により抗酸化成分の効果を十分に
発揮し、皮膚の肌荒れ及び老化防止作用に優れ、皮膚中
での活性酸素生成に起因する過酸化脂質の生成や、肌の
炎症,肌荒れを防止あるいは改善する効果を有する皮膚
外用剤を得ることを目的とした。[Problems to be Solved by the Invention] The antioxidative effect is synergistically enhanced, and the effect of antioxidative components is fully exerted by the addition of a small amount, and the effect of preventing rough skin and aging of the skin is excellent, and the active oxygen in the skin is active. The object was to obtain an external preparation for the skin, which has the effect of preventing or ameliorating the generation of lipid peroxide, the skin inflammation, and the rough skin caused by the generation.
【0005】[0005]
【課題を解決するための手段】本発明者は、前記問題点
に鑑み研究を行った結果、ソーセージノキ属植物抽出物
と、抗酸化成分を皮膚外用剤に配合することにより、抗
酸化成分の有する抗酸化効果が相乗的に増強され、少量
の配合で十分に抗酸化効果を発揮し得ることを見いだ
し、本発明を完成するに至った。Means for Solving the Problems The present inventor has conducted research in view of the above-mentioned problems, and as a result, by blending an extract of a sausage tree plant and an antioxidant component with a skin external preparation, The present inventors have found that the antioxidant effect possessed is synergistically enhanced, and that the antioxidant effect can be sufficiently exerted with a small amount of compounding, and have completed the present invention.
【0006】[0006]
【発明の実施の形態】本発明の実施の形態を説明する。BEST MODE FOR CARRYING OUT THE INVENTION Embodiments of the present invention will be described.
【0007】本発明で用いるソーセージノキ属(Kigeli
a DC.)植物は、ノウゼンカズラ科(Bignoniaceae)に属
する常緑或いは落葉の高木の双子葉植物で、アフリカに
10種あまりが分布し、栽植されている。ソーセージノ
キ属植物の抽出物を含有する化粧料は、引き締め作用に
よりバストアップ効果を発揮することが知られており
(フランス特許出願公開2759910)、これとエス
トロゲン様作用を有する植物抽出物を併用することによ
りバストのサイズアップ及びファーミング効果が得られ
ることも開示されている(国際特許出願公開2000−
002531)。Sausage genus ( Kigeli) used in the present invention
a DC.) plant is an evergreen or deciduous tree dicotyledon belonging to the family Bignoniaceae , and about 10 species are distributed and planted in Africa. It is known that cosmetics containing an extract of a sausage tree plant exhibit a bust-up effect by tightening action (French Patent Application Publication No. 2759910), and this is used in combination with a plant extract having an estrogen-like action. It is also disclosed that the bust size can be increased and a farming effect can be obtained (International Patent Application Publication 2000-
002531).
【0008】本発明においてはソーセージノキ属植物で
あれば特に限定されないが、入手の容易さから、ソーセ
ージノキ(Kigelia africana (Lamk.) Benth.)を用いる
ことが好ましい。果実,樹皮,種子,葉等各部位を用い
ることが出来るが、その効果の点から果実を用いること
が好ましい。In the present invention, there is no particular limitation as long as it is a sausage plant, but it is preferable to use sausage tree ( Kigelia africana (Lamk.) Benth.) Because it is easily available. Although various parts such as fruits, bark, seeds and leaves can be used, it is preferable to use fruits from the viewpoint of their effects.
【0009】本発明においては、ソーセージノキ属植物
は生のまま若しくは細切,乾燥,粉砕等の処理を行った
後に抽出を行う。抽出は、抽出溶媒に浸漬して行う。抽
出効率を上げるため撹拌を行ったり、抽出溶媒中でホモ
ジナイズしてもよい。抽出温度としては、5℃程度から
抽出溶媒の沸点以下の温度とするのが適切である。抽出
時間は抽出溶媒の種類や抽出温度によっても異なるが、
4時間〜2週間程度とするのが適切である。In the present invention, the sausage genus plant is extracted raw or after being subjected to treatments such as shredding, drying and crushing. The extraction is performed by immersing it in an extraction solvent. It may be stirred or homogenized in an extraction solvent in order to improve the extraction efficiency. As the extraction temperature, it is appropriate to set the temperature to about 5 ° C. to a temperature not higher than the boiling point of the extraction solvent. The extraction time depends on the type of extraction solvent and the extraction temperature,
It is appropriate that the time is about 4 hours to 2 weeks.
【0010】抽出溶媒としては、水の他、メタノール,
エタノール,プロパノール,イソプロパノール等の低級
アルコール、1,3-ブチレングリコール,プロピレングリ
コール,ジプロピレングリコール,グリセリン等の多価
アルコール、エチルエーテル,プロピルエーテル等のエ
ーテル類、酢酸エチル,酢酸ブチル等のエステル類、ア
セトン,エチルメチルケトン等のケトン類などの極性有
機溶媒を用いることができ、これらより1種又は2種以
上を選択して用いる。また、生理食塩水,リン酸緩衝
液,リン酸緩衝生理食塩水等を用いてもよい。抽出の際
の植物と溶媒との比率は特に限定されないが、植物1に
対して溶媒0.1〜1000重量倍、特に抽出操作,効
率の点で、0.5〜100重量倍が好ましい。As the extraction solvent, in addition to water, methanol,
Lower alcohols such as ethanol, propanol and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin, ethers such as ethyl ether and propyl ether, esters such as ethyl acetate and butyl acetate. It is possible to use polar organic solvents such as acetone, ketones such as ethyl methyl ketone, etc., and one kind or two or more kinds are selected from these and used. Alternatively, physiological saline, phosphate buffer, phosphate buffered saline, etc. may be used. The ratio of the plant and the solvent at the time of extraction is not particularly limited, but the solvent is preferably 0.1 to 1000 times by weight the amount of the plant 1, and particularly 0.5 to 100 times by weight in terms of extraction operation and efficiency.
【0011】ソーセージノキ属植物の上記溶媒による抽
出物は、そのままでも本発明に係る皮膚外用剤に用いる
ことができるが、濃縮,乾固したものを水や極性溶媒に
再度溶解したり、或いは本発明の効果を損なわない範囲
で脱色,脱臭,脱塩等の精製処理を行ったり、カラムク
ロマトグラフィーによる分画処理を行った後に用いても
よい。また保存のため、精製処理の後凍結乾燥し、用時
に溶媒に溶解して用いることもできる。さらに、リポソ
ーム等のベシクルやマイクロカプセル等に内包させて用
いてもよい。The extract of a sausage tree plant with the above-mentioned solvent can be used as it is in the external preparation for skin according to the present invention, but the concentrated and dried product is redissolved in water or a polar solvent, or It may be used after purification treatment such as decolorization, deodorization, desalting or the like within a range not impairing the effects of the invention, or fractionation treatment by column chromatography. For storage, it can be used after being purified and then freeze-dried and dissolved in a solvent before use. Further, it may be used by being encapsulated in vesicles such as liposomes or microcapsules.
【0012】なお、ソーセージノキ属植物の抽出物の皮
膚外用剤への配合量は、特に限定されないが、あまり多
量に配合しても、その効果に変化はなく、0.01〜1
0重量%、さらには0.01〜5重量%の範囲とするこ
とが好ましい。There is no particular limitation on the amount of the extract of the sausage plant belonging to the genus Sauscinaceae added to the external preparation for skin, but even if it is added in a too large amount, the effect does not change, and it is 0.01 to 1
It is preferably 0% by weight, more preferably 0.01 to 5% by weight.
【0013】本発明で用いる抗酸化成分は、通常皮膚外
用剤に配合し得るものであれば、種類,基原を問わない
が、例えば、カロテノイド類、フラボノイド類、タンニ
ン類及び没食子酸及びその塩並びにエステル類、トコフ
ェロール及びその誘導体類、スーパーオキシドディスム
ターゼ、チオレドキシン、チオレドキシンリダクター
ゼ、ブチルヒドロキシトルエン、ブチルヒドロキシアニ
ソール等が用いられる。The antioxidant component used in the present invention may be of any kind and source as long as it can be usually added to a skin external preparation. For example, carotenoids, flavonoids, tannins and gallic acid and salts thereof can be used. In addition, esters, tocopherols and their derivatives, superoxide dismutase, thioredoxin, thioredoxin reductase, butylhydroxytoluene, butylhydroxyanisole and the like are used.
【0014】本発明で用いられるカロテノイド類として
は、種類,基原を問わず、α-カロチン,β-カロチン,
γ-カロチン,リコペン,クリプトキサンチン,ルテイ
ン(キサントフィル),ゼアキサンチン,ロドキサンチ
ン,クロセチン等が例示される。また、これらのカロテ
ノイド類をそのまま用いてもよいが、配糖体,エステル
等の誘導体を用いてもよい。The carotenoids used in the present invention, regardless of type or origin, are α-carotene, β-carotene,
γ-carotene, lycopene, cryptoxanthin, lutein (xanthophyll), zeaxanthin, rhodoxanthin, crocetin and the like are exemplified. Moreover, these carotenoids may be used as they are, but derivatives such as glycosides and esters may also be used.
【0015】本発明で用いられるフラボノイド類として
は種類,基原を問わず、フラボン,クリシン,プリメチ
ン,アピゲニン,ルテオリン等のフラボン及フラボン配
糖体類、ガランギン,ケンフェロール,フィセチン,ク
ェルセチン,ミリセチン,ルチン等のフラボノール及び
フラボノール配糖体類、ダイゼイン,ゲニステイン等の
イソフラボン及びイソフラボン配糖体類、フラバノン,
ピノセンブリン,ナリンゲニン,サクラネチン,ヘスペ
レチン,エリオジクチオール,マットイシノール等のフ
ラバノン及びフラバノン配糖体類、フラバノノール,ピ
ノバンクシン,アロマデンドリン,フスチン,タキシホ
リン,アンペロプチン等のフラバノノール及びフラバノ
ノール配糖体類、カルコン,ブテイン,カルコノカルタ
ミジン,ペジシン,ペジシニン等のカルコン及びカルコ
ン配糖体類、べンザルクマラノン,スルフレチン,レプ
トシジン,オーロイジン等のベンザルクマラノン及びベ
ンザルクマラノン配糖体類、ペラルゴニジン,シアニジ
ン,デルフィニジン等のアントシアン及びアントシアン
配糖体類等が例示される。The flavonoids used in the present invention, regardless of type or origin, include flavones, chrysin, primetin, apigenin, luteolin and other flavones and flavone glycosides, galangin, kaempferol, fisetin, quercetin, myricetin, Flavonol and flavonol glycosides such as rutin, isoflavone and isoflavone glycosides such as daidzein and genistein, flavanone,
Flavanone and flavanone glycosides such as pinocembrin, naringenin, sakuranetin, hesperetin, eriodictyol, and matisinol, flavanonol, pinobanksin, aromadendrin, fustin, taxifolin, flavanonol glycosides, chalcone, and the like. Chalcone and chalcone glycosides such as butein, chalcone cartamidine, pedicin and pedicinin, benzalcumalanone and benzalcumalanone glycosides such as benzalcumalanone, sulfuretin, leptocidin and auroidin, pelargonidin, cyanidin and delphinidin And the anthocyanin glycosides.
【0016】本発明で用いられるタンニン類は、多数の
植物、特にカシワ,ナラ等ブナ科植物の樹皮、ハゼ,ヌ
ルデ,ウルシ等ウルシ科植物の葉、カリロクの果実など
に存在する広義のタンニン酸で、ガロタンニン,ガロタ
ンニン酸等ともよばれる。タンニン類は、これら広く植
物界に分布する多数のフェノール性水酸基を持つ複雑な
芳香族化合物の総称で、アルカリ分解するとフェノール
類,フェノールカルボン酸が得られる。本発明において
は、これらの植物由来のタンニン類をそのままもしくは
精製したものを用いることができ、さらに人工的に合成
したものを用いることもできる。また、タンニンの構成
成分である没食子酸及びその塩、並びにそのエステル類
を用いることもできる。これらのタンニン類の中でも、
ハマメリス抽出物中に含まれるハマメリタンニンを用い
ることが最も好ましい。The tannins used in the present invention are tannic acids in a broad sense, which are present in many plants, especially bark of beech plants such as oak and oak, leaves of plants such as goby, nulde and sumac, and fruits of Kariroku. It is also called gallotannin or gallotannin acid. Tannins are a general term for these complex aromatic compounds having a large number of phenolic hydroxyl groups widely distributed in the plant kingdom. Phenols and phenolcarboxylic acids are obtained by alkali decomposition. In the present invention, these plant-derived tannins may be used as they are or after being purified, and artificially synthesized ones may also be used. In addition, gallic acid and its salts, which are the constituents of tannin, and its esters can also be used. Among these tannins,
Most preferably, Hamamelitannin contained in Hamamelis extract is used.
【0017】本発明で用いられるトコフェロール及びそ
の誘導体類としては特に限定されず、α-トコフェロー
ル,β-トコフェロール,γ-トコフェロール,d-トコ
フェロール,酢酸トコフェロール,ニコチン酸DL-α-
トコフェロール,コハク酸DL-α-トコフェロール等が
例示される。The tocopherol and its derivatives used in the present invention are not particularly limited, and α-tocopherol, β-tocopherol, γ-tocopherol, d-tocopherol, tocopherol acetate, DL-α-nicotinate.
Examples include tocopherol and DL-α-tocopherol succinate.
【0018】本発明においては、その他の抗酸化成分と
して、スーパーオキシドディスムターゼ,チオレドキシ
ン,チオレドキシンリダクターゼ、ブチルヒドロキシト
ルエン、ブチルヒドロキシアニソール等を配合すること
もできる。In the present invention, superoxide dismutase, thioredoxin, thioredoxin reductase, butylhydroxytoluene, butylhydroxyanisole and the like may be added as other antioxidant components.
【0019】本発明においては、上記の抗酸化成分から
1種を単独で若しくは2種以上を組み合わせて用いるこ
とができる。また、これらの抗酸化成分の皮膚外用剤へ
の配合量は、各抗酸化成分の抗酸化活性に依存するが、
概ね0.00001〜5重量%,好ましくは0.000
1〜5重量%が適当である。In the present invention, one of the above antioxidant components may be used alone or two or more of them may be used in combination. Further, the amount of these antioxidant components to be added to the external preparation for skin depends on the antioxidant activity of each antioxidant component,
About 0.00001 to 5% by weight, preferably 0.000
1-5% by weight is suitable.
【0020】本発明においては、ソーセージノキ属植物
抽出物と、抗酸化成分を含有させた皮膚外用剤を提供し
得るが、皮膚外用剤としては、ローション,乳剤,クリ
ーム,軟膏等の形態をとることができる。またさらに、
柔軟性化粧水,収れん性化粧水,洗浄用化粧水などの化
粧水類、エモリエントクリーム,モイスチュアクリー
ム,マッサージクリーム,クレンジングクリーム,メイ
クアップクリーム等のクリーム類、エモリエント乳液,
モイスチュア乳液,ナリシング乳液,クレンジング乳液
などの乳液類、ゼリー状パック,ピールオフパック,洗
い流しパック,粉末パックなどのパック類、美容液、及
び洗顔料といった種々の製剤形態の化粧料としても提供
することができる。In the present invention, a skin external preparation containing a sausage tree plant extract and an antioxidant component can be provided, and the skin external preparation takes the form of a lotion, emulsion, cream, ointment, or the like. be able to. Furthermore,
Lotions such as flexible lotion, astringent lotion, lotion for cleaning, emollient cream, moisture cream, massage cream, cleansing cream, creams such as makeup cream, emollient emulsion,
It can also be provided as cosmetics in various formulations such as moisture emulsions, nourishing emulsions, cleansing emulsions, jelly-like packs, peel-off packs, wash-off packs, powder packs and other packs, beauty essences, and facial cleansers. it can.
【0021】本発明においてはさらに、細胞賦活剤,美
白成分,保湿剤,抗炎症剤,紫外線吸収剤等、他の有効
成分を併用することもでき、日焼け止め化粧料,老化防
止用化粧料、美白剤などの薬用化粧料あるいは医薬部外
品などとして提供することもできる。In the present invention, other active ingredients such as a cell activating agent, a whitening ingredient, a moisturizing agent, an anti-inflammatory agent and an ultraviolet absorber can also be used in combination, and a sunscreen cosmetic, an antiaging cosmetic, It can also be provided as a cosmeceutical such as a whitening agent or a quasi drug.
【0022】[0022]
【実施例】さらに実施例により、本発明の特徴について
詳細に説明する。まず、本発明で用いる、ソーセージノ
キ属植物抽出物の調製例を示す。EXAMPLES The features of the present invention will be described in more detail with reference to examples. First, a preparation example of a sausage plant extract used in the present invention is shown.
【0023】[ソーセージノキ属植物抽出物]ソーセー
ジノキ(Kigelia africana (Lamk.) Benth.)の果実50
0gを粉砕し、5000gの50重量%エタノール水溶
液中に浸漬し、25℃で24時間撹拌抽出を行った。抽
出物をろ過してろ液を回収し、ミリポアフィルターにて
除菌して、ソーセージノキ属植物抽出物を得た。[Sausage tree extract] Fruit 50 of sausage tree ( Kigelia africana (Lamk.) Benth.)
0 g was pulverized, immersed in 5000 g of a 50 wt% ethanol aqueous solution, and subjected to stirring extraction at 25 ° C. for 24 hours. The extract was filtered and the filtrate was collected and sterilized with a Millipore filter to obtain a sausage plant extract.
【0024】ソーセージノキ属植物抽出物を用いた実施
例により、本発明の特徴について詳細に説明する。ま
ず、抗酸化成分と、ソーセージノキ属植物抽出物を表1
に示すように配合し、下記の処方にて皮膚用クリームを
調製し、実施例1〜実施例4及び比較例1〜比較例6と
した。The characteristics of the present invention will be described in detail by way of examples using an extract of a sausage genus plant. First, the antioxidant components and the sausage tree plant extract are shown in Table 1.
The skin cream was prepared according to the following formulation and prepared as Examples 1 to 4 and Comparative Examples 1 to 6.
【0025】
[実施例1〜実施例4,比較例1〜比較例6]皮膚用クリーム
(1)ミツロウ 6.0(重量%)
(2)セタノール 5.0
(3)還元ラノリン 8.0
(4)スクワラン 37.5
(5)脂肪酸グリセリン 4.0
(6)親油型モノステアリン酸グリセリン 2.0
(7)ポリオキシエチレン(20EO)
ソルビタンモノラウレート 2.0
(8)プロピレングリコール 5.0
(9)パラヒドロキシ安息香酸メチル 0.1
(10)精製水 全量を100とする量
(11)表1に示す成分 記載の通り
(12)香料 0.2
製法:(1)〜(7)の油相成分を混合,溶解して均一と
し、75℃に加熱する。一方、(8)〜(10)の水相成分を
混合,溶解して75℃に加熱する。次いで、上記水相成
分に油相成分を添加して予備乳化した後、ホモミキサー
にて均一に乳化する。その後冷却し、50℃にて(11),
(12)を添加,混合する。Examples 1 to 4, Comparative Examples 1 to 6 Skin Cream (1) Beeswax 6.0 (wt%) (2) Cetanol 5.0 (3) Reduced Lanolin 8.0 ( 4) squalane 37.5 (5) fatty acid glycerin 4.0 (6) lipophilic glyceryl monostearate 2.0 (7) polyoxyethylene (20EO) sorbitan monolaurate 2.0 (8) propylene glycol 5. 0 (9) Methyl parahydroxybenzoate 0.1 (10) Purified water Amount based on 100 (11) Ingredients shown in Table 1 (12) Perfume 0.2 Manufacturing method: (1) to (7) The oil phase components of are mixed and dissolved to make uniform, and heated to 75 ° C. On the other hand, the water phase components (8) to (10) are mixed, dissolved and heated to 75 ° C. Next, the oil phase component is added to the above aqueous phase component to carry out preliminary emulsification, and then uniformly emulsified with a homomixer. After that, cool down at 50 ℃ (11),
Add (12) and mix.
【0026】[0026]
【表1】 [Table 1]
【0027】前記実施例1〜実施例4及び比較例1〜比
較例6を用いて、紫外線によるしわの発生に対する防止
効果を評価した。しわ発生防止効果の評価は、ヘアレス
マウス5匹を1群とし、各群について実施例及び比較例
をそれぞれ1日1回背部に塗布し、1J/cm2/週の
長波長紫外線(UVA)を50週間照射し、ヘアレスマ
ウスにおけるしわの発生状況を観察し、表2に示す判定
基準に従って点数化して行った。この際、精製水のみを
塗布した群を対照とした。結果は各群の平均値を算出
し、UVA照射日数との関係により表3に示した。Using Examples 1 to 4 and Comparative Examples 1 to 6, the effect of preventing the generation of wrinkles due to ultraviolet rays was evaluated. The evaluation of the wrinkle prevention effect was carried out by treating 5 hairless mice as one group, and applying an example and a comparative example to the back once a day for each group, and applying 1 J / cm 2 / week of long wavelength ultraviolet light (UVA). Irradiation was carried out for 50 weeks, and the occurrence of wrinkles in hairless mice was observed, and scored according to the criteria shown in Table 2. At this time, a group to which only purified water was applied served as a control. The results are shown in Table 3 by calculating the average value of each group and the relationship with the number of UVA irradiation days.
【0028】[0028]
【表2】 [Table 2]
【0029】[0029]
【表3】 [Table 3]
【0030】表3に示されるように、各種成分を単独で
配合した比較例1〜比較例5,若しくは配合していない
比較例6と比較して、ソーセージノキ属植物抽出物と抗
酸化成分を併用して配合した本発明の実施例では、各成
分の配合量が少ないにもかかわらず、しわの発生が顕著
に抑制され、50週後に微小なしわが僅かに発生してい
る程度であった。As shown in Table 3, as compared with Comparative Examples 1 to 5 in which various components were blended alone, or Comparative Example 6 in which various components were not blended, the sausage tree plant extract and the antioxidant component were compared. In the examples of the present invention, which were used in combination, the wrinkles were remarkably suppressed and the minute wrinkles were slightly generated after 50 weeks, even though the amounts of the respective components were small.
【0031】次に本発明の実施例1〜実施例4及び比較
例1〜比較例6について、6ヶ月間の実使用試験を行っ
た。パネラーとして、顕著なしわの発生若しくは弾性の
低下等の皮膚症状を有する40歳〜60歳代の女性、及
び顕著な肌荒れ症状を呈する20歳〜50歳代の女性を
用い、それぞれ1群20名とした。使用試験は、各群に
実施例及び比較例のそれぞれをブラインドにて使用さ
せ、使用試験開始前と使用試験終了後の皮膚の状態を観
察して行った。しわ及び皮膚弾性の各改善状況について
は、「改善」,「やや改善」,「変化なし」の3段階に
て評価し、各評価を得たパネラー数にて表4に示した。
なお、しわの程度については、写真撮影及びレプリカに
より、皮膚弾性についてはキュートメーターにより測定
して評価した。また、肌荒れについては、表5に示す判
断基準に従って皮膚の状態を点数化し、20名の平均値
により使用試験開始前と使用試験終了後を比較して表6
に示した。Next, a practical use test for 6 months was conducted on Examples 1 to 4 and Comparative Examples 1 to 6 of the present invention. As panelists, women in their 40's to 60's who have skin symptoms such as remarkable wrinkles or decreased elasticity, and women in their 20's to 50's who have remarkable skin irritation symptoms, each group 20 people And The use test was carried out by allowing each group to use each of the example and the comparative example blindly and observing the skin condition before the start of the use test and after the end of the use test. Each of the improvement states of wrinkles and skin elasticity was evaluated in three stages of “improvement”, “slight improvement” and “no change”, and the number of panelists who obtained each evaluation is shown in Table 4.
The degree of wrinkles was evaluated by taking photographs and replicas, and the skin elasticity was evaluated by measuring with a cute meter. Regarding skin roughness, the skin condition was scored according to the criteria shown in Table 5, and the average value of 20 persons was used to compare before use test start and after use test end.
It was shown to.
【0032】[0032]
【表4】 [Table 4]
【0033】表4に示されるように、本発明の実施例使
用群ではしわ及び皮膚弾性の改善が認められないパネラ
ーは存在せず、16名以上のパネラーにおいて明確な改
善が認められた。一方、比較例1〜比較例5使用群にお
いては、しわ及び弾性の改善傾向が認められたが、明確
な改善が認められたパネラーの数は全て10名以下であ
った。As shown in Table 4, in the groups used in the examples of the present invention, no panelists showed no improvement in wrinkles and skin elasticity, and a clear improvement was observed in 16 or more panelists. On the other hand, in the use groups of Comparative Examples 1 to 5, wrinkles and elasticity were tended to be improved, but the number of panelists who showed a clear improvement was 10 or less.
【0034】[0034]
【表5】 [Table 5]
【0035】[0035]
【表6】 [Table 6]
【0036】表6に示されるように、本発明の実施例使
用群では、全パネラーにおいて、肌荒れの改善傾向が認
められ、殆どのパネラーにおいて、皮溝,皮丘が明瞭に
認められるに至っていた。これに対し、各種成分を単独
で配合した比較例1〜比較例5においては、各種成分を
配合していない比較例6より皮膚の状態が改善されてい
たが、皮溝が平坦で皮丘の形が不明瞭な状態にとどまっ
ていた。As shown in Table 6, in the groups used in Examples of the present invention, all the panelists showed an improvement tendency of rough skin, and most of the panelists were able to clearly see the sulcus and the cuticle. . On the other hand, in Comparative Examples 1 to 5 in which various components were blended alone, the skin condition was improved as compared with Comparative Example 6 in which various components were not blended, but the skin groove was flat, and The shape remained unclear.
【0037】なお、本発明の実施例1〜実施例4につい
ては、上記使用試験期間中に含有成分の析出,分離,凝
集,変臭,変色といった製剤の状態変化は全く見られな
かった。また、各実施例使用群において、皮膚刺激性反
応や皮膚感作性反応を示したパネラーは存在しなかっ
た。In Examples 1 to 4 of the present invention, no change in the preparation state such as precipitation, separation, aggregation, discoloration or discoloration of the contained components was observed during the use test period. In addition, in each of the groups used in each Example, no panelists showed skin irritation reaction or skin sensitization reaction.
【0038】続いて本発明の他の実施例の処方を示す。Next, the formulation of another embodiment of the present invention will be shown.
【0039】 [実施例5] 頭髪用トニック剤 (1)精製水 30.0(重量%) (2)エタノール 69.0 (3)ソーセージノキ属植物抽出物 0.5 (4)ブチルヒドロキシトルエン 0.5 製法:(1)〜(4)の成分を混合,均一化する。[0039] [Example 5] Tonic agent for hair (1) Purified water 30.0 (wt%) (2) Ethanol 69.0 (3) Sausage tree plant extract 0.5 (4) Butylhydroxytoluene 0.5 Manufacturing method: Components (1) to (4) are mixed and homogenized.
【0040】
[実施例6] 皮膚用乳剤
(1)スクワラン 5.0(重量%)
(2)白色ワセリン 2.0
(3)ミツロウ 0.5
(4)ソルビタンセスキオレエート 0.8
(5)ポリオキシエチレンオレイルエーテル(20EO) 1.2
(6)リコペン 0.2
(7)パラオキシ安息香酸メチル 0.1
(8)プロピレングリコール 5.0
(9)精製水 59.4
(10)カルボキシビニルポリマー(1重量%水溶液) 20.0
(11)水酸化カリウム 0.1
(12)ソーセージノキ属植物抽出物 0.5
(13)エタノール 5.0
(14)香料 0.2
製法:(1)〜(6)の油相成分を混合し、75℃に加熱し
て溶解,均一化する。一方、(7)〜(9)の水相成分を混
合,溶解して75℃に加熱し、前記の油相成分を添加し
て予備乳化する。(10)を添加した後ホモミキサーにて均
一に乳化し、(11)を加えてpHを調整する。冷却後40
℃にて(12)〜(14)を添加,混合する。Example 6 Skin Emulsion (1) Squalane 5.0 (wt%) (2) White Vaseline 2.0 (3) Beeswax 0.5 (4) Sorbitan sesquioleate 0.8 (5) Polyoxyethylene oleyl ether (20EO) 1.2 (6) Lycopene 0.2 (7) Methyl paraoxybenzoate 0.1 (8) Propylene glycol 5.0 (9) Purified water 59.4 (10) Carboxyvinyl polymer (1 wt% aqueous solution) 20.0 (11) Potassium hydroxide 0.1 (12) Sausage plant extract 0.5 (13) Ethanol 5.0 (14) Perfume 0.2 Manufacturing method: (1) ~ The oil phase components of (6) are mixed and heated to 75 ° C. to dissolve and homogenize. On the other hand, the water phase components (7) to (9) are mixed and dissolved and heated to 75 ° C., and the above oil phase components are added to carry out preliminary emulsification. After adding (10), homogenize with a homomixer, and add (11) to adjust the pH. 40 after cooling
Add (12) to (14) at ℃ and mix.
【0041】 [実施例7] 皮膚用ローション (1)エタノール 10.0(重量%) (2)ヒドロキシエチルセルロース 1.0 (3)ソーセージノキ属植物抽出物 0.5 (4)パラオキシ安息香酸メチル 0.1 (5)グリセリン 5.0 (6)ハマメリタンニン 0.02 (7)精製水 83.38 製法:(1)〜(7)を混合し、均一とする。[0041] Example 7 Skin lotion (1) Ethanol 10.0 (wt%) (2) Hydroxyethyl cellulose 1.0 (3) Sausage tree plant extract 0.5 (4) Methyl paraoxybenzoate 0.1 (5) Glycerin 5.0 (6) Hamamelitannin 0.02 (7) Purified water 83.38 Manufacturing method: (1) to (7) are mixed to make uniform.
【0042】
[実施例8] 皮膚用乳剤
(1)ステアリン酸 0.2(重量%)
(2)セタノール 1.5
(3)ワセリン 3.0
(4)流動パラフィン 7.0
(5)ポリオキシエチレン(10EO)モノオレイン酸エステル 1.5
(6)ダイズ由来イソフラボン 0.5
(7)グリセリン 5.0
(8)パラオキシ安息香酸メチル 0.1
(9)トリエタノールアミン 1.0
(10)精製水 79.2
(11)ソーセージノキ属植物抽出物 1.0
製法:(1)〜(6)の油相成分を混合,加熱して均一に溶
解し、70℃に保つ。一方、(7)〜(10)の水相成分を混
合,加熱して均一とし、70℃とする。この水相成分に
油相成分を撹拌しながら徐々に添加して乳化し、冷却し
た後40℃にて(11)の成分を添加,混合する。Example 8 Skin Emulsion (1) Stearic Acid 0.2 (wt%) (2) Cetanol 1.5 (3) Vaseline 3.0 (4) Liquid Paraffin 7.0 (5) Polyoxy Ethylene (10EO) monooleate 1.5 (6) Soybean-derived isoflavone 0.5 (7) Glycerin 5.0 (8) Methyl paraoxybenzoate 0.1 (9) Triethanolamine 1.0 (10) Purification Water 79.2 (11) Sausage tree plant extract 1.0 Manufacturing method: The oil phase components of (1) to (6) are mixed and heated to uniformly dissolve, and kept at 70 ° C. On the other hand, the water phase components (7) to (10) are mixed and heated to homogenize the mixture to 70 ° C. The oil phase component is gradually added to this water phase component while stirring to emulsify, and after cooling, the component (11) is added and mixed at 40 ° C.
【0043】
[実施例9] 皮膚用ゲル剤
(1)精製水 92.8(重量%)
(2)カルボキシビニルポリマー 0.5
(3)ジプロピレングリコール 5.0
(4)パラオキシ安息香酸メチル 0.1
(5)dl-α-トコフェロール2-L-アスコルビン酸
リン酸ジエステル 0.5
(6)水酸化カリウム 0.1
(7)ソーセージノキ属植物抽出物 1.0
製法:(1)に(2)を均一に溶解した後、(3)に(4)及び
(5)を溶解して添加し、次いで(6)を加えて増粘させ、
(7)の成分を添加する。[Example 9] Gel for skin (1) Purified water 92.8 (% by weight) (2) Carboxyvinyl polymer 0.5 (3) Dipropylene glycol 5.0 (4) Methyl paraoxybenzoate 0 1 (5) dl-α-tocopherol 2-L-ascorbic acid phosphoric acid diester 0.5 (6) potassium hydroxide 0.1 (7) sausage plant extract 1.0 Production method: (1) ( After evenly dissolving 2), add (4) and (3) to (3)
(5) is dissolved and added, then (6) is added to increase the viscosity,
Add the component (7).
【0044】
[実施例10] 皮膚用クリーム
(1)ミツロウ 6.0(重量%)
(2)セタノール 5.0
(3)還元ラノリン 8.0
(4)スクワラン 29.5
(5)親油型グリセリンモノステアリン酸エステル 4.0
(6)ポリオキシエチレン(20EO)
ソルビタンモノラウリン酸エステル 5.0
(7)プロピレングリコール 5.0
(8)パラオキシ安息香酸メチル 0.1
(9)精製水 36.2
(10)ソーセージノキ属植物抽出物 1.0
(11)α-グルコシルルチン 0.2
製法:(1)〜(6)の油相成分を混合,溶解して75℃に
加熱する。一方、(7)〜(9)の水相成分を混合,溶解し
て75℃に加熱する。次いで、上記水相成分に油相成分
を添加して予備乳化した後、ホモミキサーにて均一に乳
化し、冷却後40℃にて(10),(11)の成分を添加,混合
する。Example 10 Skin Cream (1) Beeswax 6.0 (wt%) (2) Cetanol 5.0 (3) Reduced Lanolin 8.0 (4) Squalane 29.5 (5) Lipophilic Type Glycerin monostearate 4.0 (6) Polyoxyethylene (20EO) sorbitan monolaurate 5.0 (7) Propylene glycol 5.0 (8) Methyl paraoxybenzoate 0.1 (9) Purified water 36.2 (10) Sausage genus plant extract 1.0 (11) α-glucosylrutin 0.2 Production method: The oil phase components of (1) to (6) are mixed, dissolved and heated to 75 ° C. On the other hand, the aqueous phase components (7) to (9) are mixed, dissolved and heated to 75 ° C. Next, the oil phase component is added to the above aqueous phase component for preliminary emulsification, then it is uniformly emulsified with a homomixer, and after cooling, the components (10) and (11) are added and mixed at 40 ° C.
【0045】
[実施例11] 水中油型乳剤性軟膏
(1)白色ワセリン 25.0(重量%)
(2)ステアリルアルコール 25.0
(3)d-δ-トコフェロール 0.1
(4)グリセリン 10.0
(5)ラウリル硫酸ナトリウム 1.0
(6)パラオキシ安息香酸メチル 0.1
(7)精製水 37.8
(8)ソーセージノキ属植物抽出物 1.0
製法:(1)〜(3)の油相成分を混合,溶解して均一と
し、75℃に加熱する。一方、(4)〜(7)を均一にに溶
解して75℃に加熱し、これに前記油相成分を添加して
乳化し、冷却後40℃にて(8)を添加,混合する。Example 11 Oil-in-Water Emulsion Ointment (1) White Vaseline 25.0 (wt%) (2) Stearyl Alcohol 25.0 (3) d-δ-Tocopherol 0.1 (4) Glycerin 10 0.0 (5) Sodium lauryl sulfate 1.0 (6) Methyl paraoxybenzoate 0.1 (7) Purified water 37.8 (8) Sausage plant extract 1.0 Manufacturing method: (1) to (3) The oil phase components of are mixed and dissolved to make uniform, and heated to 75 ° C. On the other hand, (4) to (7) are uniformly dissolved and heated to 75 ° C., the oil phase component is added thereto to emulsify, and after cooling, (8) is added and mixed at 40 ° C.
【0046】
[実施例12] 化粧水
(1)エタノール 10.0(重量%)
(2)1,3-ブチレングリコール 10.0
(3)ソーセージノキ属植物抽出物 0.5
(4)ガラクトシルフラボン 0.5
(5)香料 0.1
(6)精製水 78.9
製法:(1)〜(5)を順次(6)に添加して均一に混合,溶
解する。[Example 12] Lotion (1) Ethanol 10.0 (wt%) (2) 1,3-Butylene glycol 10.0 (3) Sausage plant extract 0.5 (4) Galactosyl flavone 0.5 (5) Perfume 0.1 (6) Purified water 78.9 Production method: (1) to (5) are sequentially added to (6) and uniformly mixed and dissolved.
【0047】
[実施例13] 油中水乳化型エモリエントクリーム
(1)流動パラフィン 30.0(重量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)L-グルタミン酸ナトリウム 1.6
(6)L-セリン 0.4
(7)プロピレングリコール 3.0
(8)パラオキシ安息香酸メチル 0.1
(9)精製水 51.3
(10)香料 0.1
(11)ソーセージノキ属植物抽出物 0.5
(12)没食子酸メチルエステル 1.0
製法:(5),(6)を(9)の一部に溶解して50℃とし、
50℃に加熱した(4)に撹拌しながら徐々に添加する。
これをあらかじめ混合し、70℃に加熱溶解した(1)〜
(3)に均一に分散し、これに(7),(8)を(9)の残部に
溶解して70℃に加熱したものを撹拌しながら添加し、
ホモミキサーにて乳化する。冷却後、40℃にて(10)〜
(12)の成分を添加,混合する。[Example 13] Water-in-oil emulsified emollient cream (1) Liquid paraffin 30.0 (wt%) (2) Microcrystalline wax 2.0 (3) Vaseline 5.0 (4) Diglycerin oleic acid Ester 5.0 (5) L-Glutamic acid sodium 1.6 (6) L-serine 0.4 (7) Propylene glycol 3.0 (8) Methyl paraoxybenzoate 0.1 (9) Purified water 51.3 ( 10) Fragrance 0.1 (11) Sausage tree plant extract 0.5 (12) Gallic acid methyl ester 1.0 Manufacturing method: (5), (6) are dissolved in a part of (9) to 50 ° C. age,
Gradually add to (4) heated to 50 ° C. with stirring.
This was mixed in advance and dissolved by heating at 70 ° C (1) ~
Disperse evenly in (3), add (7) and (8) to the rest of (9) and heat to 70 ° C. with stirring,
Emulsify with a homomixer. After cooling, at 40 ℃ (10) ~
Add (12) and mix.
【0048】
[実施例14] メイクアップベースクリーム
(1)ステアリン酸 12.0(重量%)
(2)セタノール 2.0
(3)グリセリントリ-2-エチルヘキサン酸エステル 2.5
(4)自己乳化型グリセリンモノステアリン酸エステル 2.0
(5)葛根由来イソフラボン 0.5
(6)プロピレングリコール 10.0
(7)水酸化カリウム 0.3
(8)精製水 68.1
(9)酸化チタン 1.0
(10)ベンガラ 0.1
(11)黄酸化鉄 0.4
(12)香料 0.1
(13)ソーセージノキ属植物抽出物 1.0
製法:(1)〜(5)の油相成分を混合し、75℃に加熱し
て均一とする。一方、(6)〜(8)の水相成分を混合し、
75℃に加熱,溶解して均一とし、これに(9)〜(11)の
顔料を添加し、ホモミキサーにて均一に分散させる。こ
の水相成分に前記油相成分を添加し、ホモミキサーにて
乳化した後冷却し、40℃にて(12),(13)の成分を添
加,混合する。[Example 14] Makeup base cream (1) Stearic acid 12.0 (% by weight) (2) Cetanol 2.0 (3) Glycerin tri-2-ethylhexanoate 2.5 (4) Self Emulsified glycerin monostearate 2.0 (5) Kuzukon-derived isoflavone 0.5 (6) Propylene glycol 10.0 (7) Potassium hydroxide 0.3 (8) Purified water 68.1 (9) Titanium oxide 1 0 (10) Red iron oxide 0.1 (11) Yellow iron oxide 0.4 (12) Perfume 0.1 (13) Sausage genus plant extract 1.0 Manufacturing method: Oil phase components of (1) to (5) Are mixed and heated to 75 ° C. to homogenize. On the other hand, by mixing the water phase components (6) to (8),
It is heated to 75 ° C. and melted to make it uniform, and the pigments (9) to (11) are added thereto and dispersed uniformly by a homomixer. The oil phase component is added to the aqueous phase component, the mixture is emulsified by a homomixer and then cooled, and the components (12) and (13) are added and mixed at 40 ° C.
【0049】
[実施例15] 乳液状ファンデーション
(1)ステアリン酸 2.0(重量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)デカグリセリンモノイソパルミチン酸エステル 9.0
(6)リコペン 0.5
(7)1,3-ブチレングリコール 8.0
(8)水酸化カリウム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 50.6
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)ソーセージノキ属植物抽出物 0.5
製法:(1)〜(6)の油相成分を混合し、75℃に加熱し
て均一とする。一方、(7)〜(10)の水相成分を混合し、
75℃に加熱,溶解して均一とし、これに(11)〜(15)の
顔料を添加し、ホモミキサーにて均一に乳化した後冷却
し、40℃にて(16),(17)の成分を添加,混合する。Example 15 Milky liquid foundation (1) Stearic acid 2.0 (wt%) (2) Squalane 5.0 (3) Octyldodecyl myristate 5.0 (4) Cetanol 1.0 (5) Decaglycerin monoisopalmitate 9.0 (6) Lycopene 0.5 (7) 1,3-butylene glycol 8.0 (8) Potassium hydroxide 0.1 (9) Methyl paraoxybenzoate 0.1 (10 ) Purified water 50.6 (11) Titanium oxide 9.0 (12) Talc 7.4 (13) Red iron oxide 0.5 (14) Yellow iron oxide 1.1 (15) Black iron oxide 0.1 (16) Perfume 0.1 (17) Sausage tree plant extract 0.5 Production method: Mix the oil phase components of (1) to (6) and heat to 75 ° C. to homogenize. On the other hand, by mixing the water phase components (7) to (10),
Heat to 75 ° C to dissolve and homogenize, add the pigments of (11) to (15) to this, homogenize with a homomixer, and then cool, and cool to 40 ° C at (16) and (17). Add and mix the ingredients.
【0050】
[実施例16] ハンドクリーム
(1)セタノール 4.0(重量%)
(2)ワセリン 2.0
(3)流動パラフィン 10.0
(4)グリセリンモノステアリン酸エステル 1.5
(5)ポリオキシエチレン(60EO)
グリセリンイソステアリン酸エステル 2.5
(6)酢酸トコフェロール 0.5
(7)グリセリン 20.0
(8)パラオキシ安息香酸メチル 0.1
(9)精製水 57.4
(10)ソーセージノキ属植物抽出物 1.0
(11)ハマメリタンニン 1.0
製法:(1)〜(6)の油相成分を混合,溶解して75℃に
加熱する。一方、(7)〜(9)の水相成分を混合,溶解し
て75℃に加熱する。ついで、水相成分に油相成分を添
加して予備乳化した後、ホモミキサーにて均一に乳化し
て冷却し、40℃にて(10)及び(11)の成分を添加,混合
する。Example 16 Hand Cream (1) Cetanol 4.0 (wt%) (2) Vaseline 2.0 (3) Liquid Paraffin 10.0 (4) Glycerin Monostearate 1.5 (5) Polyoxyethylene (60EO) glycerin isostearic acid ester 2.5 (6) Tocopherol acetate 0.5 (7) Glycerin 20.0 (8) Methyl paraoxybenzoate 0.1 (9) Purified water 57.4 (10) Sausage Cypress plant extract 1.0 (11) Hamamelitannin 1.0 Manufacturing method: The oil phase components of (1) to (6) are mixed, dissolved and heated to 75 ° C. On the other hand, the aqueous phase components (7) to (9) are mixed, dissolved and heated to 75 ° C. Next, the oil phase component is added to the aqueous phase component to pre-emulsify it, then the mixture is uniformly emulsified with a homomixer and cooled, and the components (10) and (11) are added and mixed at 40 ° C.
【0051】[0051]
【発明の効果】ソーセージノキ属植物抽出物と抗酸化成
分を併用した本発明の皮膚外用剤は、皮膚の肌荒れ及び
老化防止作用に優れ、皮膚中での活性酸素生成に起因す
る過酸化脂質の生成や、肌の炎症,肌荒れを防止あるい
は改善する効果を示した。EFFECTS OF THE INVENTION The external preparation for skin of the present invention comprising a combination of a sausage tree plant extract and an antioxidant component is excellent in the effects of preventing rough skin and aging of the skin, and is capable of removing lipid peroxides resulting from the generation of active oxygen in the skin. It has the effect of preventing or improving the generation, inflammation of the skin and rough skin.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/48 A61K 7/48 31/015 31/015 31/05 31/05 31/085 31/085 31/192 31/192 31/352 31/352 31/355 31/355 31/7024 31/7024 35/78 35/78 C W A61P 17/00 A61P 17/00 17/16 17/16 39/06 39/06 43/00 105 43/00 105 Fターム(参考) 4C083 AA082 AA111 AA112 AB032 AB232 AB242 AB432 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC352 AC402 AC422 AC442 AC471 AC472 AC482 AC542 AC582 AC782 AC841 AC842 AD042 AD092 AD282 AD392 AD412 AD471 AD512 AD621 AD622 AD642 AD661 AD662 BB47 CC02 CC03 CC04 CC05 CC12 CC33 DD22 DD23 DD27 DD31 DD41 EE05 EE12 EE13 FF05 4C086 AA01 AA02 BA08 BA09 MA02 MA04 MA63 NA14 ZA89 ZA92 ZB21 ZC41 ZC75 4C088 AB12 AC04 AC05 AC06 BA08 BA09 BA10 CA05 CA06 CA07 CA08 CA14 MA03 MA63 NA14 ZA89 ZA92 ZB21 ZC41 ZC75 4C206 AA01 AA02 BA04 CA17 CA27 KA01 MA02 MA04 MA83 NA14 ZA89 ZA92 ZB21 ZC41 ZC75─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61K 7/48 A61K 7/48 31/015 31/015 31/05 31/05 31/085 31/085 31 / 192 31/192 31/352 31/352 31/355 31/355 31/7024 31/7024 35/78 35/78 C W A61P 17/00 A61P 17/00 17/16 17/16 39/06 39 / 06 43/00 105 43/00 105 F term (reference) 4C083 AA082 AA111 AA112 AB032 AB232 AB242 AB432 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC352 AC402 AC422 AC442 AC471 AC472 AC482 AC542 AC582 AC782 AC841 AC842 AD042 AD092 AD282 AD512 AD412 AD392 AD412 AD392 AD412 AD392 AD412 AD392 AD4621 AD642 AD661 AD662 BB47 CC02 CC03 CC04 CC05 CC12 CC33 DD22 DD23 DD27 DD31 DD41 EE05 EE12 EE13 FF05 4C086 AA01 AA02 BA08 BA09 MA02 MA04 MA63 NA14 ZA89 ZA92 ZB21 ZC41 CA06 CA14 CA14 CA14 CA14 CA14 CA14 CA14 CA14 BA14 BA08 BA09 BA08 BA09 BA08 BA09 BA08 BA09 BA14 ZA 92 ZB21 ZC41 ZC75 4C206 AA01 AA02 BA04 CA17 CA27 KA01 MA02 MA04 MA83 NA14 ZA89 ZA92 ZB21 ZC41 ZC75
Claims (3)
抽出物と、抗酸化成分から選択される1種又は2種以上
の成分を含有する皮膚外用剤。1. A skin external preparation containing a sausage tree ( Kigelia DC.) Plant extract and one or more components selected from antioxidant components.
ノイド類,タンニン類及び没食子酸及びその塩並びにエ
ステル類,トコフェロール及びその誘導体類,スーパー
オキシドディスムターゼ,チオレドキシン,チオレドキ
シンリダクターゼ、ブチルヒドロキシトルエン、ブチル
ヒドロキシアニソールから選択される1種又は2種以上
である、請求項1に記載の皮膚外用剤。2. Antioxidant components are carotenoids, flavonoids, tannins, gallic acid and its salts, and esters, tocopherol and its derivatives, superoxide dismutase, thioredoxin, thioredoxin reductase, butylhydroxytoluene, butylhydroxyanisole. The external preparation for skin according to claim 1, which is one kind or two or more kinds selected from the following.
が、ソーセージノキ(Kigelia africana (Lamk.) Bent
h.)である、請求項1又は請求項2に記載の皮膚外用
剤。3. A sausage tree ( Kigelia DC.) Plant is a sausage tree ( Kigelia africana (Lamk.) Bent.
The external preparation for skin according to claim 1 or 2, which is h.).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001336752A JP2003137727A (en) | 2001-11-01 | 2001-11-01 | Skin care preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001336752A JP2003137727A (en) | 2001-11-01 | 2001-11-01 | Skin care preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003137727A true JP2003137727A (en) | 2003-05-14 |
Family
ID=19151520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001336752A Pending JP2003137727A (en) | 2001-11-01 | 2001-11-01 | Skin care preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003137727A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007530417A (en) * | 2003-07-01 | 2007-11-01 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Composition for manipulating the longevity and stress response of cells and organisms |
JP2009507826A (en) * | 2005-09-08 | 2009-02-26 | 株式會社アモーレパシフィック | Skin external preparation composition for preventing skin aging |
US9241916B2 (en) | 2005-06-14 | 2016-01-26 | President And Fellows Of Harvard College | Cognitive performance with sirtuin activators |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0912471A (en) * | 1995-06-29 | 1997-01-14 | Noevir Co Ltd | Skin preparation for external use |
JPH09143063A (en) * | 1995-11-22 | 1997-06-03 | Kose Corp | Composition suitable for external use |
JPH09291011A (en) * | 1996-04-24 | 1997-11-11 | Kose Corp | Composition suitable for eternal use |
JPH1192332A (en) * | 1997-09-25 | 1999-04-06 | Mandom Corp | Skin preparation composition for external use |
JP2000229827A (en) * | 1999-02-05 | 2000-08-22 | Kose Corp | Skin lotion |
JP2001072571A (en) * | 1999-09-08 | 2001-03-21 | Noevir Co Ltd | Skin preparation for external use |
JP2001151633A (en) * | 1999-11-26 | 2001-06-05 | Noevir Co Ltd | Preparation for external use for skin |
-
2001
- 2001-11-01 JP JP2001336752A patent/JP2003137727A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0912471A (en) * | 1995-06-29 | 1997-01-14 | Noevir Co Ltd | Skin preparation for external use |
JPH09143063A (en) * | 1995-11-22 | 1997-06-03 | Kose Corp | Composition suitable for external use |
JPH09291011A (en) * | 1996-04-24 | 1997-11-11 | Kose Corp | Composition suitable for eternal use |
JPH1192332A (en) * | 1997-09-25 | 1999-04-06 | Mandom Corp | Skin preparation composition for external use |
JP2000229827A (en) * | 1999-02-05 | 2000-08-22 | Kose Corp | Skin lotion |
JP2001072571A (en) * | 1999-09-08 | 2001-03-21 | Noevir Co Ltd | Skin preparation for external use |
JP2001151633A (en) * | 1999-11-26 | 2001-06-05 | Noevir Co Ltd | Preparation for external use for skin |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007530417A (en) * | 2003-07-01 | 2007-11-01 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Composition for manipulating the longevity and stress response of cells and organisms |
JP2007326872A (en) * | 2003-07-01 | 2007-12-20 | Univ Harvard | Composition for manipulating the longevity and stress response of cells and organisms |
JP2012025750A (en) * | 2003-07-01 | 2012-02-09 | President & Fellows Of Harvard College | Composition for manipulating lifespan and stress response of cell and organism |
US9241916B2 (en) | 2005-06-14 | 2016-01-26 | President And Fellows Of Harvard College | Cognitive performance with sirtuin activators |
JP2009507826A (en) * | 2005-09-08 | 2009-02-26 | 株式會社アモーレパシフィック | Skin external preparation composition for preventing skin aging |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2736484B1 (en) | Botanical antioxidant compositions | |
EP1761240A1 (en) | Lupin total extract consisting of a lupin sugar extract and a lupin peptide extract, method for the production and use thereof | |
JP4685375B2 (en) | Topical skin preparation | |
JPH06336419A (en) | External agent for skin | |
JP2019210216A (en) | Skin external preparation or cosmetics | |
JP2003002819A (en) | Skin care composition | |
JP2002370922A (en) | Cosmetics containing plum extract | |
JP2006008537A (en) | External preparation for skin | |
JP2008303147A (en) | External preparation for skin | |
JP3667027B2 (en) | Topical skin preparation | |
JP4425163B2 (en) | Anti-aging cosmetics | |
JP2001072571A (en) | Skin preparation for external use | |
JP2001114636A (en) | Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion | |
JP3940633B2 (en) | Topical skin preparation | |
JP2004002219A (en) | External preparation for skin | |
JP2003137727A (en) | Skin care preparation | |
JP2002356413A (en) | Skin care preparation | |
JP3847200B2 (en) | Topical skin preparation | |
JP2002370962A (en) | Bleaching preparation and cosmetic for preventing and improving aging of skin | |
JP2003335623A (en) | Skin care preparation for external use | |
JP2003306423A (en) | Skin care preparation | |
JP2003335628A (en) | Skin care preparation for external use | |
JP2013032331A (en) | Lipid production-inhibiting agent, sebum production-inhibiting agent, and triacylglycerol production-inhibiting agent | |
JP6170314B2 (en) | Antioxidants with fu extract | |
JP3449967B2 (en) | External preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041019 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050407 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050411 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060116 |